Pule Kangni (普乐康尼)普乐康尼
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
No product-level labeled indications/safety are joined for this record.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江西南昌济生制药厂Chinese legal name: 江西南昌济生制药厂
主要成分Active Ingredients
- 二甲双胍metformin
- 其组分为格列本脲和二甲双胍Recorded Chinese composition: 其组分为格列本脲和二甲双胍
药物知识说明
二甲双胍是一种在国家药监局注册认定的药品。该药品含有二甲双胍-f91c67f9等成分。
该药品关联的活性成分包括:二甲双胍metformin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:江西南昌济生制药厂Chinese legal name: 江西南昌济生制药厂。
您可以探索含有相同成分的其他药品:二甲双胍-f91c67f9成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
metformin is a medicine registered with the national drug regulatory authority. It contains metformin as active ingredient(s).
Active ingredients associated with this product: metforminmetformin.
Manufacturers recorded for this product: 江西南昌济生制药厂Chinese legal name: 江西南昌济生制药厂.
Explore other medicines containing the same ingredient: metformin products.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 普乐康尼Recorded Chinese name: 普乐康尼
- 规格Specification: 每粒含盐酸二甲双胍250mg与格列本脲2.5mg。Recorded Chinese composition: 每粒含盐酸二甲双胍250mg与格列本脲2.5mg。
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江西南昌济生制药厂Chinese legal name: 江西南昌济生制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20060006
相关问题Questions
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.